PINAUD EXAM 2 Flashcards
basic characteristics of enzymes
increase rate by lowering AE
do not alter equilibrium constant
often require co-factors
usually proteins, sometimes RNA
highly specific to substrate and reaction
protease
catalyzes the hydrolysis of protein peptide bonds
thrombin
proteolytic enzyme in blood clotting
Cuts between Arg and Gly
trypsin
enzyme in the digestive system
cuts after Arg or Lys
holoenzyme
apoenzyme (inactive) + cofactor (coenzyme or metal)
∆G equation
∆G = ∆G° + RT ln [products]/[reactants]
Keq equation
kf/kr
3 ways to increase the rxn rate (k)
increase substrate conc.
increase T
decrease activation energy
ES complex characteristics
shape of active catalytic pocket is 3D (via steric hindrances of AA residues) and flexible, often nonpolar
induced fit: change conformation after binding
multiple weak interactions between E and S (H bonding, electrostatic, hydrophobic, VDWs)
transition state
short lived chemical state
highest peak of ∆G diagram
strong binding and flexibility of ES complex promotes formation of transition state
kinetic evidence for ES complex
rxn rate increases with increases substrate conc until a plateau (enzyme conc)
physical evidence for ES complex
x-ray crystallography
binding energy
some free energy released upon binding ES, helps form active site and lowers ∆G of transition state
enzymes speed up biochemical rxns by…
specific substrate recognition
multiple reactive steps at catalytic site
strong binding to transition state
efficient release of product
first order rxn
V = k[S], units s-1
second order rxn
V = k[S][B], units M-1 s-1
at low [S]…
Vo proportional to [S]
at high [S]…
Vo independent of [S]
Km
substrate concentration at 1/2(Vmax)
kcat
turnover rate (molecules/s), only works when Vmax has been reached
Michaelis-Menten equation
Vo = Vmax ([S]/[S] + Km)
what does Km say about the strength of ES complex?
low Km = stronger binding
high Km = weaker binding
enzyme efficiency measurement
kcat/Km
10^8 to 10^9 is catalytically perfect
lineweaver burke plot
reciprocal of Michaelis-Menten curve, linear
1/Vo = (Km/Vmax)(1/[S]) + 1/Vmax
types of reversible enzymatic inhibition
competitive, uncompetitive, noncompetitive
irreversible enzymatic inhibition
tight binding to enzyme
competitive inhibition
enzyme binds to S OR I
enzyme freed from I by increasing [S]
increases Km, Vmax unchanged
DHFR (dihydrofolate reductase)
needed for cell division
methotrexate (similar structure) = competitive inhibitor to DHFR, 1000x tighter binding, cancer drug
methotrexate
competitive inhibitor to DHFR (structurally similar)
1000x tighter binding than DHFR
cancer drug used to kill rapidly dividing cells
uncompetitive inhibition
I binds after S
ESI complex cannot make P
Vmax decreases and cannot be attained
Km decreases
High [S] does not overcome inhibition
noncompetitive inhibition
I and S bind at the same time
ESI cannot make P
Vmax decreases
high [S] does not overcome inhibition
4 types of irreversible inhibition
group specific modifying agent, affinity labels, suicide inhibitors, transition state analogs
group specific modifying agent
react with specific group at modifying site
affinity labels
inactivate enzyme by covalent modification
suicide inhibitors
chemical mechanism makes enzyme react covalently with inhibitor
transition state analog
similar to transition state structure, binds more strongly to E than S
proline racemase
enzyme that catalyzes isomerization of proline
pyrrole 2-carboxylic acid acts as transition state analog to planar proline ion (transition state)
penicillin
transition state analog and suicide inhibitor
inhibits glycopeptide transpeptidase (forms bacterial cell walls through peptide cross-linking)
statins
competitive inhibitors of HMG-CoA reductase (cholesterol synthesis)
similar structure to substrate inhibits cholesterol synthesis
reactive cleft
environment favoring S + E interaction
close proximity of substrate to active reading groups
optimized orientation of substrate for rxn
rxn protected from water / hydrolysis
aspirin
irreversible covalent inhibitor of prostaglandin H2 synthase (prostaglandin synthesis –> transmission of pain info, inflammation)
acetylation of serine residue in channel to reach active site - anti-inflammatory
induced fit
stabilizes various conformations for both E and S
optimized orientation of catalytic groups in enzyme
allows very tight binding to transition state (gives free energy to accelerate catalysis)
covalent catalysis
reactive groups of enzyme become covalently attached to substrate
covalent E-S bond highly reactive for next step
usually involves strong Nu-
acid-base catalysis
reactive groups of enzymes donate or accept a proton
involves acidic and basic AA residues
metal ion catalysis
loosely (Ca2+) or tightly (Zn2+) bound to enzyme
ionic interactions with substrate or enzyme groups
shield neg charges or stabilize charges
serine protease
uses Ser 195 as a highly reactive group for catalysis
transient covalent interaction
acetylation & deacetylation
oxyanion hole
area of active catalytic site that tightly binds tetrahedral transition intermediate, stabilizes O- charge
catalytic triad
making Ser 195 a Nu-
H-bound network between Asp 102, His 57, Ser 195
mutations within triad lead to dramatic decrease in catalytic efficiency
chymotrypsin
cuts after bulky hydrophobic AAs, Trp, Phe, Met
pocket is deep and hydrophobic
trypsin
cuts after long positive AAs Lys and Arg
Asp (-) at the bottom of pocket
elastase
cuts after AAs with small side chains, Ala and Ser
narrow pocket
cysteine protease
catalytic mech resembles Ser triad
Aspartyl protease
use Asp carboxylate group to activate H2O and attack peptide bonds
Metalloproteases
use metal ion to activate H2O
ex. carbonic anhydrase
proton shuttle
His 64 removes proton in carbonic anhydrase catalysis to achieve fast catalytic rates
“committed step”
first step that makes reaction irreversible, feedback regulation will target the product of the first committed step
homotropic effects
caused by substrate itself at catalytic sites
increase catalytic rates
heterotropic effects
caused by binding of non-substrate ligands
decrease catalytic rates
R + T states
relaxed and tense states of an enzyme, rapid switching
cooperative binding
binding of 1 substrate causes increased binding affinity for another
ATCase
allosteric enzyme involved in synthesis of pyrimidine nucleotides
end product for ATCase?
CTP, which causes negative feedback on ATCase
structure of ATCase
12 subunits: 6 catalytic and 6 regulatory
PALA
substrate analog, binding to ATCase causes large conformational changes
equilibrium toward R state
(basically a model to understand substrate binding and how it affects catalytic activity)